Anne Ørbo

1.6k total citations
53 papers, 1.2k citations indexed

About

Anne Ørbo is a scholar working on Genetics, Obstetrics and Gynecology and Immunology. According to data from OpenAlex, Anne Ørbo has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 22 papers in Obstetrics and Gynecology and 18 papers in Immunology. Recurrent topics in Anne Ørbo's work include Estrogen and related hormone effects (22 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Reproductive System and Pregnancy (17 papers). Anne Ørbo is often cited by papers focused on Estrogen and related hormone effects (22 papers), Endometrial and Cervical Cancer Treatments (20 papers) and Reproductive System and Pregnancy (17 papers). Anne Ørbo collaborates with scholars based in Norway, United States and Netherlands. Anne Ørbo's co-authors include Marit Arnes, Georg Sager, Bjørn Straume, I. Pettersen, Turid Kaino, Jan Martin Maltau, George L. Mutter, Curt W. Burger, P. J. van Diest and Knut E. Kjørstad and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer and Cancer Research.

In The Last Decade

Anne Ørbo

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Ørbo Norway 18 657 560 318 277 191 53 1.2k
Eleftherios Pierre Samartzis Switzerland 24 375 0.6× 697 1.2× 167 0.5× 241 0.9× 500 2.6× 43 1.3k
Yuji Taketani Japan 12 373 0.6× 392 0.7× 55 0.2× 429 1.5× 223 1.2× 17 908
Tomohito Tanaka Japan 18 333 0.5× 338 0.6× 78 0.2× 97 0.4× 348 1.8× 81 1.0k
Xia Luo China 15 216 0.3× 241 0.4× 171 0.5× 447 1.6× 367 1.9× 23 1.0k
Ilana Chefetz United States 19 753 1.1× 78 0.1× 184 0.6× 367 1.3× 420 2.2× 30 1.6k
Jeannine Villella United States 16 166 0.3× 271 0.5× 129 0.4× 311 1.1× 523 2.7× 43 1.2k
Synnöve Staff Finland 20 240 0.4× 264 0.5× 158 0.5× 79 0.3× 454 2.4× 48 1.2k
Yasunari Mizumoto Japan 18 197 0.3× 194 0.3× 134 0.4× 104 0.4× 340 1.8× 50 833
Hector Arango United States 10 202 0.3× 432 0.8× 373 1.2× 47 0.2× 455 2.4× 15 1.2k
Xingbo Ζhao China 17 316 0.5× 318 0.6× 81 0.3× 250 0.9× 327 1.7× 49 811

Countries citing papers authored by Anne Ørbo

Since Specialization
Citations

This map shows the geographic impact of Anne Ørbo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Ørbo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Ørbo more than expected).

Fields of papers citing papers by Anne Ørbo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Ørbo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Ørbo. The network helps show where Anne Ørbo may publish in the future.

Co-authorship network of co-authors of Anne Ørbo

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Ørbo. A scholar is included among the top collaborators of Anne Ørbo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Ørbo. Anne Ørbo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Arnes, Marit, et al.. (2019). Intrauterine Progestin Therapy as a New Approach to Premalignant Endometrial Polyps: A Prospective Observational Study. Anticancer Research. 39(9). 4897–4903. 3 indexed citations
3.
Arnes, Marit, et al.. (2018). Significance of progesterone receptors (PR‐A and PR‐B) expression as predictors for relapse after successful therapy of endometrial hyperplasia: a retrospective cohort study. BJOG An International Journal of Obstetrics & Gynaecology. 126(7). 936–943. 9 indexed citations
4.
Arnes, Marit, et al.. (2018). Low-dose LNG-IUS as Therapy for Endometrial Hyperplasia. A Prospective Cohort Pilot Study. Anticancer Research. 38(5). 2883–2889. 6 indexed citations
5.
Arnes, Marit, et al.. (2017). Prediction of Relapse After Therapy Withdrawal in Women with Endometrial Hyperplasia: A Long-term Follow-up Study. Anticancer Research. 37(5). 2529–2536. 8 indexed citations
6.
Ørbo, Anne, et al.. (2016). HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia. British Journal of Cancer. 115(6). 725–730. 12 indexed citations
7.
Sager, Georg, et al.. (2012). Increased gene expression of the ABCC5 transporter without distinct changes in the expression of PDE5 in human cervical cancer cells during growth.. PubMed. 32(8). 3055–61. 14 indexed citations
8.
Ørbo, Anne, et al.. (2010). Down‐regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system. Acta Obstetricia Et Gynecologica Scandinavica. 89(11). 1438–1446. 25 indexed citations
9.
Ørbo, Anne, et al.. (2010). MCF-7 cell apoptosis and cell cycle arrest: non-genomic effects of progesterone and mifepristone (RU-486).. PubMed. 30(12). 4835–40. 26 indexed citations
10.
11.
Ørbo, Anne, et al.. (2008). Treatment results of endometrial hyperplasia after prospective D-score classification. Gynecologic Oncology. 111(1). 68–73. 79 indexed citations
12.
Ørbo, Anne, et al.. (2008). Early effects of high concentrations of progesterone and Mifepristone A gene expression study of endometrial cancer cells (Ishikawa). The Journal of Steroid Biochemistry and Molecular Biology. 113(1-2). 139–149. 13 indexed citations
13.
Paulssen, Ruth H., et al.. (2007). Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 73(1). 116–128. 15 indexed citations
14.
Kaino, Turid, et al.. (2005). Bcl-2, BAX, and apoptosis in endometrial hyperplasia after high dose gestagen therapy. Gynecologic Oncology. 97(3). 740–750. 45 indexed citations
15.
16.
Sager, Georg, et al.. (2003). Non-genomic effects of progestins—inhibition of cell growth and increased intracellular levels of cyclic nucleotides. The Journal of Steroid Biochemistry and Molecular Biology. 84(1). 1–8. 23 indexed citations
17.
Maltau, Jan Martin, et al.. (2002). Computerised morphometric study of the paraurethral tissue in young and elderly women. Neurourology and Urodynamics. 21(6). 529–533. 14 indexed citations
18.
Baak, Jan P. A., Anne Ørbo, P. J. van Diest, et al.. (2001). Prospective Multicenter Evaluation of the Morphometric D-Score for Prediction of the Outcome of Endometrial Hyperplasias. The American Journal of Surgical Pathology. 25(7). 930–935. 56 indexed citations
19.
20.
Ørbo, Anne. (2000). Vellykket kreftbehandling – men hva så?. Tidsskrift for Den Norske Laegeforening. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eleftherios Pierre Samartzis Breakdown of academic impact, for papers by Yuji Taketani Breakdown of academic impact, for papers by Tomohito Tanaka Breakdown of academic impact, for papers by Xia Luo Breakdown of academic impact, for papers by Ilana Chefetz Breakdown of academic impact, for papers by Jeannine Villella Breakdown of academic impact, for papers by Synnöve Staff Breakdown of academic impact, for papers by Yasunari Mizumoto Breakdown of academic impact, for papers by Hector Arango Breakdown of academic impact, for papers by Xingbo Ζhao
Rankless by CCL
2026